MD&A Archives - Capital Markets

Topic: MD&A

SEC Reminds Companies That Earnings Management Can Have MD&A Consequences

by Stan Keller, Rob Evans and Eugene McDermott | May 5, 2021 | 1934 Act Filings, Disclosure Requirements, Enforcement Actions, MD&A

In a settled enforcement action against Under Armour Inc. announced on May 3, 2020 the SEC reminded companies that managing earnings, even if accounted for correctly, can have MD&A implications triggering disclosure obligations. According to the SEC order, Under Armour, in order to meet analyst projections and sustain its 20% quarter over quarter revenue growth record, pressured customers to move purchases forward into the current quarter, and did this for a number of consecutive quarters.

SEC Revision of MD&A – Focus on Future Uncertainties Disclosure

by Stan Keller, Rob Evans and Eugene McDermott | Dec 10, 2020 | 1934 Act Filings, Disclosure Requirements, MD&A

The Securities and Exchange Commission has continued its effort to update and ‎streamline the disclosure requirements for filings with the SEC. In November, the SEC adopted ‎amendments to the rules for Management’s Discussion and Analysis and related financial ‎disclosures. ‎ ‎ MD&A, because of its principles-based nature, is among the most challenging of ‎the disclosure requirements.‎

Topic: MD&A

SEC Reminds Companies That Earnings Management Can Have MD&A Consequences

SEC Revision of MD&A – Focus on Future Uncertainties Disclosure

Search

Topics

Archives

Email the Editors

Share

Locke Lord LLP

Follow Us